ResMed Inc.
RMD
Classement en actions
#707
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Prix de l'action
$245.56
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$34.54B
Changement (1 jour)
2.47%
Changement (1 an)
-8.45%
Pays
US
Échange ResMed Inc. (RMD)
Catégorie
Healthcare
Ratio P/E pour ResMed Inc. (RMD)
Ratio P/E au October 2026 TTM : 22.54
Selon les derniers rapports financiers et le cours de l'action de ResMed Inc., le ratio P/E actuel (TTM) est de 22.54. À la fin de l’année 2024, le P/E de l’entreprise était de 26.92.
Historique du ratio P/E pour ResMed Inc. de 2000 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | 22.54 | -16.59% |
| 2025 | 27.02 | 0.38% |
| 2024 | 26.92 | -24.65% |
| 2023 | 35.73 | -9.05% |
| 2022 | 39.28 | -47.96% |
| 2021 | 75.49 | 69.35% |
| 2020 | 44.58 | 1.83% |
| 2019 | 43.78 | -6.58% |
| 2018 | 46.86 | 45.70% |
| 2017 | 32.16 | 27.81% |
| 2016 | 25.16 | 12.14% |
| 2015 | 22.44 | 8.16% |
| 2014 | 20.75 | -0.27% |
| 2013 | 20.80 | 16.45% |
| 2012 | 17.86 | -14.08% |
| 2011 | 20.79 | -13.89% |
| 2010 | 24.14 | 14.81% |
| 2009 | 21.03 | -16.13% |
| 2008 | 25.07 | -47.48% |
| 2007 | 47.74 | 24.01% |
| 2006 | 38.49 | 10.09% |
| 2005 | 34.97 | 16.65% |
| 2004 | 29.97 | 5.79% |
| 2003 | 28.33 | 18.64% |
| 2002 | 23.88 | -82.35% |
| 2001 | 135.33 | 272.77% |
| 2000 | 36.30 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 33.11 | 46.91% |
US
|
|
| 21.39 | -5.10% |
IE
|
|
| 28.94 | 28.43% |
US
|
|
| 17.34 | -23.07% |
US
|
|
| - | - |
DE
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.